Navigation Links
HMS Holdings Corp. to Present at the Sidoti & Co. 13th Annual New York Emerging Growth Institutional Investor Forum
Date:3/18/2009

NEW YORK, March 18 /PRNewswire-FirstCall/ -- HMS Holdings Corp. (Nasdaq: HMSY) today announced that it will present at the Sidoti & Co. 13th Annual New York Emerging Growth Institutional Investor Forum at the Grand Hyatt New York City.

The Company will present on Wednesday, March 25th at 10:25 am Eastern Time.

HMS Holdings Corp. is the leader in coordination of benefits and program integrity services for government healthcare programs. The company's clients include health and human services programs in more than 40 states, 90 managed care plans, the Centers for Medicare and Medicaid Services (CMS), and Veterans Administration facilities. HMS helps ensure that healthcare claims are paid correctly and by the responsible party. As a result of the company's services, government healthcare programs recover over $1 billion annually, and avoid billions of dollars more in erroneous payments. HMS is headquartered in New York and operates offices nationwide.


'/>"/>
SOURCE HMS Holdings Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. China Pharma Holdings, Inc. Reports Record 2008 Year End Financial Results and Corporate Updates
2. Innophos Holdings, Inc. Declares Quarterly Dividend
3. China Pharma Holdings, Inc. to Host Fourth Quarter 2008 Earnings Conference Call at 8:30 a.m. EDT Wednesday March 18, 2009
4. Level 3 Provides Primary Connectivity for MDI Holdings
5. Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results
6. SETO Holdings, Inc. Signs Letter of Intent to Dispose of all its Existing Businesses and Acquire Advanced Hearing Centers, Inc.; New Management to be Installed.
7. HMS Holdings Corp. Announces Executive Promotions
8. InfuSystem Holdings Reports 12.9% Revenue Increase and $3.3 Million of Adjusted EBITDA for the Fourth Quarter of 2008
9. Zimmer Holdings Names Marc Casper to Board of Directors
10. King Size Combo: New Report Reveals Broad Toll on Taxpayers by Bailed-Out Bank Goldman Sachs and Its Holdings in Burger King
11. Innophos Holdings, Inc. Elects John M. Steitz as New Independent Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... ... July 25, 2017 , ... SignatureCare Emergency Center – South Austin is treating ... Hours a day. , The Emergency Room opened early March, making ... four months now and things are running smoothly,” said Aaron Braun, SignatureCare Emergency Center’s ...
(Date:7/24/2017)... MO (PRWEB) , ... July 24, 2017 , ... ... acclaimed Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI), part of Saint ... basis since 2016. , Cheerag D. Upadhyaya, MD. M.Sc., FAANS joins Stanley ...
(Date:7/24/2017)... ... July 24, 2017 , ... BayMark Health Services has ... Services Administration’s (SAMHSA) State Targeted Response to the Opioid Crisis program. The ... facilitate the development of a hub and spoke model for opioid treatment in ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... in scholarship awards to be awarded annually to and divided between two full-time ... in bringing awareness to Amazonian plant medicine. To apply for the scholarship, students ...
(Date:7/24/2017)... ... , ... Axiad IDS , a leading provider of trusted identities for ... to expand its solution to help government contractors more quickly and cost-effectively comply ... to address the authentication requirements within NIST SP800-171, but no matter how you ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... agreed to schedule an End-of-Phase II meeting with Oramed ... oral insulin capsule ORMD-0801 in the treatment of type ... secondary endpoints by indicating a statistically significant lowering of ...
(Date:7/10/2017)... -- The tenth annual BioPharm America™ will take ... the Sheraton Boston Hotel, September 26–27. The event will ... makers and innovative biotech startup companies. The event is ... impactful days. BioPharm America is now part of Biotech ... with 4,500+ life science industry influencers participating in 8+ ...
Breaking Medicine Technology: